Rallybio Corporation (RLYB)
0.92
0.03 (3.37%)
At close: Jan 15, 2025, 1:10 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -74.56M | -66.65M | -47.01M | -26.45M | -17.56M |
| Depreciation & Amortization | 150.00K | 167.00K | 109.00K | 62.00K | 26.00K |
| Stock-Based Compensation | 10.92M | 9.50M | 3.65M | 704.00K | 194.00K |
| Other Working Capital | 4.38M | -1.42M | -2.80M | 1.40M | 1.34M |
| Other Non-Cash Items | -1.05M | 640.00K | 1.50M | 1.52M | 144.00K |
| Deferred Income Tax | n/a | n/a | n/a | n/a | 103.00K |
| Change in Working Capital | 4.28M | -936.00K | -3.78M | 2.12M | 2.07M |
| Operating Cash Flow | -60.27M | -57.28M | -45.53M | -22.04M | -15.03M |
| Capital Expenditures | -12.00K | -54.00K | -333.00K | -137.00K | -188.00K |
| Acquisitions | -2.25M | -300.00K | -2.00M | -1.94M | n/a |
| Purchase of Investments | -110.66M | -201.32M | -2.00M | -1.94M | n/a |
| Sales Maturities Of Investments | 138.33M | 89.50M | 2.00M | 1.94M | n/a |
| Other Investing Acitivies | 2.25M | -112.12K | -2.00K | -1.94K | n/a |
| Investing Cash Flow | 27.66M | -112.17M | -2.33M | -2.07M | -188.00K |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | 282.00K | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 143.00K | -455.00K | -3.23M | -319.00K | -33.00K |
| Financial Cash Flow | 143.00K | 51.08M | 82.97M | 144.89M | 31.57M |
| Net Cash Flow | -32.46M | -118.38M | 35.10M | 120.78M | 16.35M |
| Free Cash Flow | -60.28M | -57.34M | -45.87M | -22.18M | -15.21M |